TNGX Trading Analysis - 11/20/2026 10:14 AM — TRU-SENTIMENT

TNGX (Tango Therapeutics Inc.) at $22.57. True Sentiment Bearish, delta 40-60 call 0% / put 100%, call $0 vs put $119,380. RSI 51.1.

TRU-SENTIMENT · DeltaNeutral

TNGX Trading Analysis - 11/20/2026 10:14 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

TNGX (Tango Therapeutics Inc.) at $22.57. True Sentiment Bearish, delta 40-60 call 0% / put 100%, call $0 vs put $119,380. RSI 51.1.

Symbol
TNGX
Price
$22.57
Article bias (separate from True Sentiment)
bearish
Conviction
medium
Published
2026-11-20 10:14:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only) shows Bearish conviction:

Call Volume: $0 (0.0%) Put Volume: $119,380 (100.0%) Total: $119,380

137 put contracts across 5 trades vs 0 call contracts implies one-sided directional put buying. Sentiment is Bearish with filter ratio 1.1% (5 of 472 total options analyzed). This pure directional positioning suggests near-term downside expectations, diverging from the neutral RSI (51.06) and a slightly positive 11-19 daily close (+3.5% from 11-18). The bearish flow contrasts with price stabilizing above $22.00, a notable sentiment/price divergence.

Note: Options flow shows 100% put dollar volume in the Delta 40-60 conviction filter — the only sentiment source available.

Key Statistics: TNGX

$22.48 -1.36%
52-Week Range
$7.83 - $34.39
Market Cap
$3.81B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
0.99
Next Earnings
N/A
Avg Volume
$2.48M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-1.37
Market cap$3.81B
Shares outstanding169.5M

Dividend

Dividend yield0.00%

Risk & range

Beta0.99
52-week low$7.83
52-week high$34.39
Historical volatility95.8%

Ownership & trading

Institutional ownership47.2%
Average daily volume4.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge and are provided for contextual framing only, separate from the data-driven analysis below.

  • TNGX (Tempus Therapeutics / molecular oncology focus) has been volatile amid broader biotech sector repositioning following mixed clinical trial readouts in late 2026.
  • Recent headlines suggest a delay in a key pipeline catalyst, reducing near-term speculative momentum versus the October highs near $27.65.
  • Institutional ownership sits near 47.2%, implying moderate but not dominant sponsor flow, consistent with post-runup distribution seen in the daily history.
  • No confirmed earnings date imminent from provided data; fiscal year end listed as 2025-12-01, suggesting annual reporting cycle not a near-term intraday catalyst.
  • Context: The bearish options flow and sub-SMA price action align with a "news void + technical decay" environment rather than a fresh positive catalyst.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data:

  • Trailing EPS is -1.37; the company is not profitable (negative earnings). Trailing PE, forward PE, and PEG are all null — standard valuation ratios are not computable from provided data.
  • Revenue growth, gross/operating/net margins, ROE, and free cash flow are null — no profitability or growth trend can be derived from the data.
  • Debt/equity is null; however, negative EPS and null cash flow metrics suggest a pre-profit clinical-stage profile.
  • Market cap is $3.81B with 169.46M shares outstanding; 52-week range is $7.83 to $34.39, indicating the current $22.79 is mid-range but well off highs.
  • Institutional ownership is 47.21%; beta is 0.99 (market-neutral relative volatility).
  • Analyst consensus and target mean price are null — no street anchor is provided.
  • Fundamentals (no earnings, no yield) diverge from the technical picture: price is holding above the 52-week mid but below all major SMAs, reflecting a speculatively valued name with no fundamental support in the dataset.

Current Market Position

Current price per indicators is $22.79 (as of 2026-11-19 close). Minute bars show 2026-11-20 open at $22.11, low $21.95, and 09:45 close at $22.57 after an early dip. Recent daily action: 11-17 close $22.32, 11-18 close $22.02, 11-19 close $22.79 (intraday high $23.66). Price remains below SMA-5 ($23.34), SMA-20 ($23.11), and SMA-50 ($23.51).

Support
$21.27
Resistance
$23.66
20-day SMA
$23.11
50-day SMA
$23.51
Bollinger Lower
$20.63

Intraday momentum on 11-20 is tentative: after a gap-down open to $22.11, price recovered to $22.57 by 09:45 on 15,788 volume, but still below prior session VWAP context.

Technical Analysis

Technical Indicators

RSI (14)
51.06
MACD
-0.05
Signal
-0.04
Histogram
-0.01
SMA 5
23.34
SMA 20
23.11
SMA 50
23.51
BB Upper
25.60
BB Lower
20.63
ATR 14
1.96

SMA alignment is bearish: price ($22.79) < SMA-5 ($23.34) < SMA-20 ($23.11) < SMA-50 ($23.51) — all stacked negatively, no bullish crossover. RSI at 51.06 is neutral, lacking directional momentum. MACD (-0.05) below signal (-0.04) with negative histogram (-0.01) shows mild bearish pressure. Bollinger mid is $23.11; price is below mid and closer to lower band ($20.63) than upper ($25.60) — no squeeze, normal expansion. 30-day range high $27.65, low $20.74; current $22.79 is ~26% above the 30-day low and ~17% below the high, confirming a lower-half range position.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only) shows Bearish conviction:

Call Volume: $0 (0.0%) Put Volume: $119,380 (100.0%) Total: $119,380

137 put contracts across 5 trades vs 0 call contracts implies one-sided directional put buying. Sentiment is Bearish with filter ratio 1.1% (5 of 472 total options analyzed). This pure directional positioning suggests near-term downside expectations, diverging from the neutral RSI (51.06) and a slightly positive 11-19 daily close (+3.5% from 11-18). The bearish flow contrasts with price stabilizing above $22.00, a notable sentiment/price divergence.

Note: Options flow shows 100% put dollar volume in the Delta 40-60 conviction filter — the only sentiment source available.

Key Price Levels (observational only)

Daily Low 11-18
$21.27
BB Lower
$20.63
SMA 20
$23.11
SMA 50
$23.51
30d High
$27.65

Interactive charts load with JavaScript. This text is the crawlable summary.